Program Start: 7:30 AM - 9:00 AM Registration Begins 30 minutes prior.
Join us at our annual September Kickoff Event, Visionary New England CEOs Speak. Jeff Leiden, CEO, Vertex, Roger Crandall, CEO, MassMutual, and Sheila Marcelo, CEO, Care.com will share a glimpse into their boardrooms as they discuss the outlook for 2019 and beyond.
Jeff Leiden, CEO, Vertex
Jeff is the chairman, president and CEO of Vertex Pharmaceuticals. He is a physician scientist who, for the last 30 years, has dedicated his career to improving the lives of people with serious diseases. Under his leadership, Vertex has brought patients the first and only medicines to treat the underlying cause of cystic fibrosis (CF), and is now developing a medicine that could reach 90% of people living with this devastating disease.
He began his career in academia as a molecular biologist and practicing cardiologist. From 1987 to 2000, Dr. Leiden held several academic and hospital appointments, including roles as Chief of Cardiology, the Rawson Professor of Medicine and Pathology, and an Attending Physician at the University of Chicago, the Elkan R. Blout Professor of Biological Sciences at the Harvard School of Public Health, and Professor of Medicine at Harvard Medical School. During his academic career, he was also involved in starting several biotechnology companies including Vical and Cardiogene.
From 2000 to 2006, he served as President and Chief Operating Officer and Chief Scientific Officer at Abbott Laboratories where he had responsibility for running Abbott’s global pharmaceuticals business. While at Abbott, Dr. Leiden led the development and launch of multiple breakthrough medicines, including HUMIRA® (adalimumab) for rheumatoid arthritis and other autoimmune diseases and KALETRA® (lopinavir/ritonavir) for HIV infection.
He also held a number of industry board positions, including as a director of Abbott Laboratories and TAP, non-executive Vice Chairman of Shire Pharmaceuticals Plc and director of Millennium Pharmaceuticals, Inc. From 2006 to 2011, he was a Managing Director of Clarus Ventures, a life sciences venture capital firm. There he was dedicated to developing new treatments through the creation of innovative biotech companies.
Dr. Leiden has served as a member of Vertex’s board of directors since 2009 and as Chairman and CEO since 2012. Under his leadership, Vertex has delivered the first and only precision medicines to treat the underlying cause of cystic fibrosis (CF). It is his mission and the basis of the company’s research priorities to bring transformative medicines to people with CF and other serious diseases. Dr. Leiden also cares deeply about inspiring and equipping under-resourced students and young women to become the next generation of scientific leaders. He established a signature program at Vertex to enhance STEAM education among students in our local communities, including an on-site Learning Lab, mentorship programs, internships and college scholarships. In 2017, Vertex announced a sustained corporate giving commitment of $500 million over the next 10 years, of which $50 million is focused on STEAM education.
In addition to his responsibilities at Vertex, Dr. Leiden is currently a director of Path AI, Quest Diagnostics, and the Massachusetts Mutual Life Insurance Company, chair of the Scientific Advisory Board of the Brigham and Women’s Hospital and a member of the Scientific Advisory Board of Boston Children’s Hospital. Dr. Leiden also serves on the board of directors of the Massachusetts Competitive Partnership, the board of fellows of Harvard Medical School, the board of directors of the Museum of Fine Arts and the Boston Private Industry Council and as co-chair of Massachusetts Governor Charlie Baker’s STEM Advisory Council and the Mass Digital Health Council. He is a fellow of the American Academy of Arts and Sciences and an elected member of the National Academy of Medicine.
Sheila Lirio Marcelo, CEO, Care.com
Sheila is founder, chairwoman and CEO of Care.com. She founded the company in 2006 after her personal challenges as a young working mother finding care for two small children and ailing parents shed a spotlight on the massive care needs of families everywhere. Today, the publicly traded company is the world’s largest online destination for finding and managing family care, serving more than 28 million people across 20 countries.
Committed to building a company that can be both profitable and mission-based, Sheila continues to drive innovation across Care.com’s platforms and services to enable families to find care and caregivers to find meaningful work, while also leveraging the company’s data and reach to drive systemic change across the care economy as a whole.
Prior to founding Care.com, Sheila was an Entrepreneur in Residence at Matrix Partners and held executive positions at Upromise, helping families save for college and at executive search engine TheLadders.com. She is a member of the Board of Trustees of Boston Children’s Hospital, sits on the Library of Congress Trust Fund Board, and is a member of the Massachusetts Competitive Partnership. Sheila graduated from Mount Holyoke College and received her J.D. and M.B.A. degrees from Harvard University.
Roger Crandall, CEO, MassMutual
Roger is chairman, president and chief executive officer of MassMutual. During his tenure as CEO, MassMutual has grown to serve more than five million customers, provide nearly $670 billion in life insurance protection and reached more than $770 billion in assets under management. The company is also the number-one writer of whole life insurance in the United States.
Mr. Crandall first joined MassMutual in 1988 as a real estate investment trainee, and spent the first 12 years of his career in the company’s Investment Management Department. In 2000, he joined Babson Capital, a MassMutual subsidiary which is now part of Barings, where he gradually assumed broader management responsibilities in such areas as public and private bonds, bank loans and private equity investments. In 2005, Mr. Crandall was appointed Chairman of Babson Capital and MassMutual’s Chief Investment Officer, and in 2007, he added the role of Co-Chief Operating Officer. He was named MassMutual’s President and joined the company’s Board of Directors in 2008, and was named CEO in 2010.
In addition to his role at MassMutual, Mr. Crandall takes an active leadership role in industry, civic, academic and economic development organizations. He is a member of the Business Roundtable and also serves on the Smithsonian National Board, the American Council of Life Insurers Executive Committee, the Massachusetts Competitive Partnership, the Wharton Board of Leadership Advisors, the University of Vermont Foundation Leadership Council and the Lahey Hospital & Medical Center Board of Trustees. Mr. Crandall, a Chartered Financial Analyst (CFA), is a graduate of the University of Vermont with a bachelor’s degree in Economics. He earned his MBA with honors from the Wharton School of Business at the University of Pennsylvania.
Moderator - Cathy Minehan
Cathy E. Minehan is an active profit and not for profit board member of entities engaged in major commercial activity, healthcare and education. She is the Managing Director of Arlington Advisory Partners LLC and has a wealth of experience in over 45 years at various executive and CEO levels.
Ms. Minehan retired from the Federal Reserve Bank of Boston in July 2007 after 39 years with the Federal Reserve System, having served as the President and Chief Executive of the Boston Bank and a member of the Federal Open Market Committee from July 1994 on.
From August 2011 to June 2016 she served as Dean of the School of Management at Simmons College, known for its MBA for women and for it’s all on-line offerings. Ms. Minehan is a graduate of the University of Rochester and is a member of the University’s Board of Trustees. She holds an MBA from New York University and was named a distinguished Alumna from New York University in 1995.
Currently, Ms. Minehan is a director of Bright Horizons Family Solutions LLC, The MITRE Corporation and the Brookings Institution. She is Chair of the Board of Trustees of the Massachusetts General Hospital and a Board Member of Partners Healthcare System. She is co-chair of the Boston Women’s Workforce Council which works to end the gender wage gap in Boston. She is also a member of the board of the Museum of Fine Arts in Boston, and of the board of WGBH, a public broadcasting station in Boston.
She is an elected fellow of the American Academy of Arts and Sciences and was named the Public Company Director of the Year (New England NACD 2012); NACD Top 100 Directors in 2013; and 2015 Shattuck City Champion (Boston). She is the recipient of many other honors and distinctions.